Literature DB >> 9539637

Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients.

V Savarino1, G S Mela, P Zentilin, M A Cimmino, M Parisi, M R Mele, M Pivari, G Bisso, G Celle.   

Abstract

The use of NSAIDs is strongly associated with peptic ulceration. The inhibition of prostaglandin synthesis with the consequent increase of gastric acidity is considered a possible mechanism. Therefore we decided to assess the effect of one-month treatment with NSAIDs on the circadian gastric pH of rheumatoid arthritis (RA) patients. We studied 11 consecutive patients (one man and 10 women, median age 55, range 26-72 years) with confirmed RA. None was H. pylori positive. A 24-hr gastric pH recording was performed both in basal conditions and after one-month treatment with either indomethacin 150 mg/day (eight cases) or ketoprofen 300 mg/day (three cases). Only the 10 female patients were eligible for final analysis, and six matched healthy subjects not taking NSAIDs were used as control group. The number of 24-hr pH readings for various pH thresholds was calculated for both populations. The highest acid levels (pH < 3.0) did not differ between the two pH profiles of the control group (7440 vs 7391, P = NS), while they predominated after the one-month NSAID treatment (10,339 vs 11,440, P < 0.001) in RA patients. These findings show that there is an increased gastric acidity after one-month of treatment with NSAIDs in female patients with RA of recent onset. This may sustain the rationale of using antisecretory agents to prevent gastroduodenal ulcerations in these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539637     DOI: 10.1023/a:1018834301901

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases.

Authors:  G S Mela; V Savarino; M Moretti; G Bonifacino; A Sumberaz; P Zentilin
Journal:  Scand J Gastroenterol       Date:  1989-08       Impact factor: 2.423

2.  Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

Authors:  T K Daneshmend; A G Stein; N K Bhaskar; C J Hawkey
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 3.  Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword.

Authors:  D R Lichtenstein; S Syngal; M M Wolfe
Journal:  Arthritis Rheum       Date:  1995-01

4.  Prostaglandin E2 and gastric acid secretion in man.

Authors:  A Bennett; I F Stamford; W G Unger
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

5.  Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.

Authors:  P Ekström; L Carling; S Wetterhus; P E Wingren; O Anker-Hansen; G Lundegårdh; E Thorhallsson; P Unge
Journal:  Scand J Gastroenterol       Date:  1996-08       Impact factor: 2.423

6.  Effects of indomethacin on intragastric pH and meal-stimulated serum gastrin secretion in rheumatoid arthritis patients.

Authors:  M Janssen; L C Baak; J B Jansen; B A Dijkmans; J P Vandenbroucke; C B Lamers
Journal:  Aliment Pharmacol Ther       Date:  1993-08       Impact factor: 8.171

7.  Effect of indomethacin on gastric acid and bicarbonate secretion in humans.

Authors:  M Feldman; T J Colturi
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

8.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

Authors:  M R Griffin; J M Piper; J R Daugherty; M Snowden; W A Ray
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

9.  Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis.

Authors:  T J de Witte; P J Geerdink; C B Lamers; A M Boerbooms; J K van der Korst
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

10.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

Authors:  E M el-Omar; I D Penman; J E Ardill; R S Chittajallu; C Howie; K E McColl
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

View more
  6 in total

1.  Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia.

Authors:  Yoshikazu Kinoshita; Shunji Ishihara
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

Review 2.  NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.

Authors:  Jørgen Naesdal; Kurt Brown
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial.

Authors:  Takashi Kondo; Hiroo Sei; Takahisa Yamasaki; Toshihiko Tomita; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2017-01-24       Impact factor: 7.527

4.  Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers.

Authors:  Masafumi Nishino; Mitsushige Sugimoto; Chise Kodaira; Mihoko Yamade; Naohito Shirai; Mutsuhiro Ikuma; Tatsuo Tanaka; Haruhiko Sugimura; Akira Hishida; Takahisa Furuta
Journal:  Dig Dis Sci       Date:  2009-08-12       Impact factor: 3.199

Review 5.  Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.

Authors:  Marco Lazzaroni; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 6.  Management of Osteoarthritis: Expert Opinion on NSAIDs.

Authors:  Alberto Magni; Piergiuseppe Agostoni; Cesare Bonezzi; Giuseppe Massazza; Paolo Menè; Vincenzo Savarino; Diego Fornasari
Journal:  Pain Ther       Date:  2021-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.